Blog

Risperdal Lawsuits Continue to Mount

Risperdal is an atypical antipsychotic approved by the U.S Food & Drug Administration to treat schizophrenia, bipolar disorder, and irritability in children with autistic disorder. Unfortunately, the medication has proven to pose serious risks to male children and adults, including gynecomastia (male chest growth) and significant weight gain. As of December 2014, 2014, court documents indicate that 1,183 claims have been filed in Pennsylvania on behalf of individuals who developed gynecomastia or other serious complications. This represents an increase of more than 100 filings in the past month. (In Re: Risperdal Litigation, Case Number 100300296).

Tell Us About Your Case

If you can read this, please avoid filling the following input field or your submission may be marked as spam.
Thank you for contacting us! We will be in touch with you shortly.

Recent Entries

Archive

Locks Law Firm only provides legal advice after having entered into an attorney client relationship, which our website specifically does not create. Conversations that originate from website messaging, chat or other two way web based engagement  do not create an attorney client relationship. It is imperative that any action taken be done on the advice of counsel. Because every case is different, the description of awards and cases previously handled do not guarantee a similar outcome in current or future cases. The firm practices law in Pennsylvania, New Jersey & New York as Locks Law Firm. Super Lawyers, Best Lawyers in America and other organizations that rate attorneys are not designations that have been approved by the State Supreme Courts or the American Bar Association.